Agmatine, an endogenous imidazoline receptor ligand modulates ethanol anxiolysis and withdrawal anxiety in rats

European Journal of Pharmacology

Volumn 637, Issue 1-3, 2010, Pages 89-101

  Taksande, Brijesh G ^a   Kotagale, Nandkishor R ^a   Patel, Mital R ^a   Shelkar, Gajanan P ^a   Ugale, Rajesh R ^a   Chopde, Chandrabhan T ^a  

^a India   (India)

Author keywords

Agmatine; EPM (elevated plus maze); Ethanol; Imidazoline receptor; Withdrawal anxiety

Indexed keywords

2 (2 BENZOFURANYL) 2 IMIDAZOLINE HYDROCHLORIDE; AGMATINE; ALCOHOL; AMINOGUANIDINE; ARCAINE; ARGININE; CLONIDINE; EFAROXAN; EFLORNITHINE; IDAZOXAN; IMIDAZOLE DERIVATIVE; IMIDAZOLINE I1 RECEPTOR; MOXONIDINE; UNCLASSIFIED DRUG;

ALCOHOL WITHDRAWAL; ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; BRAIN LEVEL; CONTROLLED STUDY; DRUG ALCOHOL INTERACTION; DRUG EFFICACY; DRUG RECEPTOR BINDING; MAZE TEST; NONHUMAN; PHARMACOLOGICAL BLOCKING; PRIORITY JOURNAL; RAT; TRANQUILIZING ACTIVITY;

AGMATINE; ANIMALS; ANTI-ANXIETY AGENTS; ANXIETY; ARGININE; BIGUANIDES; BRAIN; CLONIDINE; DOSE-RESPONSE RELATIONSHIP, DRUG; EFLORNITHINE; ETHANOL; GUANIDINES; IMIDAZOLES; IMIDAZOLINE RECEPTORS; LIGANDS; MAZE LEARNING; RATS; RATS, SPRAGUE-DAWLEY; SUBSTANCE WITHDRAWAL SYNDROME;

EID: 77953288503     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejphar.2010.03.058     Document Type: Article

References (111)

1. Adell A., Myers R.D. Increased alcohol intake in low alcohol drinking rats after chronic infusion of the beta-carboline harman into the hippocampus. Pharmacol. Biochem. Behav. 1994, 49:949-953.
2. Aricioglu F., Means A., Regunathan S. Effect of agmatine on the development of morphine dependence in rats: potential role of cAMP system. Eur. J. Pharmacol. 2004, 504:191-197.
3. Aricioglu-Kartal F., Uzbay I.T. Inhibitory effect of agmatine on naloxone-precipitated abstinence syndrome in morphine dependent rats. Life Sci. 1997, 61:1775-1781.
4. Askalany A.R., Yamakura T., Petrenko A.B., Kohno T., Sakimura K., Baba H. Effect of agmatine on heteromeric N-methyl-d-aspartate receptor channels. Neurosci. Res. 2005, 52:387-392.
5. Baldwin H.A., Rassnick S., Rivier J., Koob G.F., Britton K.T. CRF antagonist reverses the "anxiogenic" response to ethanol withdrawal in the rat. Psychopharmacology 1991, 103:227-232.
6. Bedford A., McIver D., Foulds, "general instability" and "psychopathy"16PF scales and their relationship to psychiatric mood state. J. Clin. Psychol. 1978, 34:417-418.
7. Belzung C., Berton F. Further pharmacological validation of the BALB/c neophobia in the free exploratory paradigm as an animal model of trait anxiety. Behav. Pharmacol. 1997, 8:541-548.
8. Bence A.K., Worthen D.R., Stables J.P., Crooks P.A. An in vivo evaluation of the antiseizure activity and acute neurotoxicity of agmatine. Pharmacol. Biochem. Behav. 2003, 74:771-775.
9. Bertoglio L.J., Carobrez A.P. Prior maze experience required to alter midazolam effects in rats submitted to the elevated plus-maze. Pharmacol. Biochem. Behav. 2002, 72:449-455.
10. Bilkei-Gorzo A., Gyertyan I., Levay G. mCPP-induced anxiety in the light-dark box in rats- a new method for screening anxiolytic activity. Psychopharmacology (Berl.) 1998, 136:291-298.
11. Chandler L.J., Sutton G., Norwood D., Sumners C., Crews F.T. Chronic ethanol increases N-methyl-d-aspartate-stimulated nitric oxide formation but not receptor density in cultured cortical neurons. Mol. Pharmacol. 1997, 51:733-740.
12. Costa E.T., Ferreira V.M., Valenzuela C.F. Evidence that nitric oxide regulates the acute effects of ethanol on rat N-methyl-d-aspartate receptors in vitro. Neurosci. Lett. 2003, 343:41-44.
13. Dalvi A., Rodgers R.J. GABAergic influences on plus-maze behaviour in mice. Psychopharmacology 1996, 128:380-397.
14. Dandekar M.P., Singru P.S., Kokare D.M., Lechan R.M., Thim L., Clausen J.T., Subhedar N.K. Importance of cocaine- and amphetamine-regulated transcript peptide in the central nucleus of amygdala in anxiogenic responses induced by ethanol withdrawal. Neuropsychopharmacology 2008, 33:1127-1136.
15. Davidson M., Wilce P. Chronic ethanol treatment leads to increased ornithine decarboxylase activity: implications for a role of polyamines in ethanol dependence and withdrawal. Alcohol Clin. Exp. Res. 1998, 22:1205-1211.
16. Davis M. Neurobiology of fear responses: the role of the amygdala. J. Neuropsychiatry Clin. Neurosci. 1997, 9:382-402.
17. De Vos H., Bricca G., De Keyser J., De Backer J.P., Bousquet P., Vauquelin G. Imidazoline receptors, non-adrenergic idazoxan binding sites and alpha 2-adrenoceptors in the human central nervous system. Neuroscience 1994, 59:589-598.
18. Dobrydnjov I., Axelsson K., Berggren L., Samarütel J., Holmström B. Intrathecal and oral clonidine as prophylaxis for postoperative alcohol withdrawal syndrome: a randomized double-blinded study. Anesth. Analg. 2004, 98:738-744.
19. Durcan M.J., Lister R.G. Time course of ethanol's effects on locomotor activity, exploration and anxiety in mice. Psychopharmacology (Berl.) 1988, 96:67-72.
20. Durcan M.J., Lister R.G., Linnoila M. Behavioral effects of alpha 2 adrenoceptor antagonists and their interactions with ethanol in tests of locomotion, exploration and anxiety in mice. Psychopharmacology (Berl.) 1989, 97:189-193.
21. El-Mas M.M., Abdel-Rahman A.A. Effect of long-term ethanol feeding on brainstem alpha(2)-receptor binding in Wistar-Kyoto and spontaneously hypertensive rats. Brain Res. 2001, 900:324-328.
22. Fadda F., Mosca E., Colombo G., Gessa G.L. Effect of spontaneous ingestion of ethanol on brain dopamine metabolism. Life Sci. 1989, 44:281-287.
23. Feng Y., LeBlanc M.H., Regunathan S. Agmatine reduces extracellular glutamate during pentylenetetrazole-induced seizures in rat brain: a potential mechanism for the anticonvulsive effects. Neurosci. Lett. 2005, 390:129-133.
24. Ferreira V.M.M., Valenzuela C.F., Morato G.S. Role of nitric oxide-dependent pathways in ethanol induced anxiolytic effects in rats. Alcohol Clin. Exp. Res. 1999, 23:1898-1904.
25. Galea E., Regunathan S., Eliopoulos V., Feinstein D.L., Reis D.J. Inhibition of mammalian nitric oxide synthases by agmatine, an endogenous polyamine formed by decarboxylation of arginine. Biochem. J. 1996, 316:247-249.
26. Garcia-Sevilla J.A., Escriba P.V., Ozaita A., Walzer C., Guimon J. Density of imidazoline receptors in platelets of euthymic patients with bipolar affective disorder and in brains of lithium-treated rats. Biol. Psychiatry. 1998, 43:616-618.
27. Garthwaite J., Garthwaite G., Palmer R.M., Moncada S. NMDA receptor activation induces nitric oxide synthesis from arginine in rat brain slices. Eur. J. Pharmacol. 1989, 172:413-416.
28. Gatch M.B., Wallis C.J., Lal H. Effects of ritanserin on ethanol withdrawal-induced anxiety in rats. Alcohol. 2000, 21:11-17.
29. Gibson D.A., Harris B.R., Rogers D.T., Littleton J.M. Radioligand binding studies reveal agmatine is a more selective antagonist for a polyamine-site on the NMDA receptor than arcaine or ifenprodil. Brain Res. 2002, 952:71-77.
30. Gibson D.A., Harris B.R., Prendergast M.A., Hart S.R., Blanchard J.A., Holley R.C., Pedigo N.W., Littleton J.M. Polyamines contribute to ethanol withdrawal-induced neurotoxicity in rat hippocampal slice cultures through interactions with the NMDA receptor. Alcohol Clin. Exp. Res. 2003, 27:1099-1106.
31. Gong Z.H., Li Y.F., Zhao N., Yang H.J., Su R.B., Luo Z.P., Li J. Anxiolytic effect of agmatine in rats and mice. Eur. J. Pharmacol. 2006, 550:112-116.
32. Grupp L.A., Lau V., Harding S. The reduction in alcohol intake by the 5-HT1A agonist 8-OH DPAT and its attenuation by the alpha 2 adrenergic antagonist idazoxan correlates with blood glucose levels. Psychopharmacology (Berl.) 1997, 133:172-178.
33. Halaris A., Plietz J. Agmatine: metabolic pathway and spectrum of activity in brain. CNS Drugs 2007, 21:885-900.
34. Hao Y.J., Kitashiba H., Honda C., Nada K., Moriguchi T. Expression of arginine decarboxylase and ornithine decarboxylase genes in apple cells and stressed shoots. J. Exp. Botany 2005, 56:1105-1115.
35. Hernandez S., Schwarcz de Tarlovsky S. Arginine decarboxylase in Trypanosoma cruzi, characteristics and kinetic properties. Cell. Mol. Biol. (Noisy-le-grand) 1999, 45:383-391.
36. Hirani K., Sharma A.N., Jain N.S., Ugale R.R., Chopde C.T. Evaluation of GABAergic neuroactive steroid 3alpha-hydroxy-5alpha-pregnane-20-one as a neurobiological substrate for the anti-anxiety effect of ethanol in rats. Psychopharmacology (Berl.) 2005, 180:267-278.
37. Huang M.J., Regunathan S., Botta M., Lee K., McClendon Yi G.B., Pedersen M.L., Berkowitz D.B., Wang G., Travagli M., Piletz J.E. Structure-activity analysis of guanidine group in agmatine for brain agmatinase. Ann. N. Y. Acad. Sci. 2003, 1009:52-63.
38. Isome M., Lortie M.J., Murakami Y., Parisi E., Matsufuji S., Satriano J. The antiproliferative effects of agmatine correlate with the rate of cellular proliferation. Am. J. Physiol. Cell Physiol. 2007, 293:C705-C711.
39. Itzhak Y. Role of the NMDA receptor and nitric oxide in memory reconsolidation of cocaine-induced conditioned place preference in mice. Ann. N. Y. Acad. Sci. 2008, 1139:350-357.
40. Jung M.W., Qin Y., Lee D., Mook-Jung I. Relationship among discharges of neighboring neurons in the rat prefrontal cortex during spatial working memory tasks. J. Neurosci. 2000, 20:6166-6172.
41. Kokare D.M., Chopde C.T., Subhedar N.K. Participation of α-melanocyte stimulating hormone in ethanol-induced anxiolysis and withdrawal anxiety in rats. Neuropharmacology 2006, 51:536-545.
42. Koob G.F. Neurobiology of addiction. Toward the development of new therapies. Ann. N. Y. Acad. Sci. 2000, 909:170-185.
43. Koob G.F. Alcoholism: allostasis and beyond. Alcohol Clin. Exp. Res. 2003, 27:232-243.
44. LaBuda C.J., Fuchs P.N. Catecholamine depletion by reserpine blocks the anxiolytic actions of ethanol in the rat. Alcohol 2002, 26:55-59.
45. LaBuda C.J., Hale R.L. Anxiety in mice following acute aspartame and ethanol exposure. Alcohol 2000, 20:69-74.
46. Lal H., Prather P.L., Rezazadeh S.M. Anxiogenic behavior in rats during acute and protracted ethanol withdrawal: reversal by buspirone. Alcohol 1991, 8:467-471.
47. Lal H., Prather P.L., Rezazadeh S.M. Potential role of 5HT1C and/or 5HT2 receptors in the mianserin-induced prevention of anxiogenic behaviors occurring during ethanol withdrawal. Alcohol Clin. Exp. Res. 1993, 17:411-417.
48. Lavinsky D., Arteni N.S., Netto C.A. Agmatine induces anxiolysis in the elevated plus maze task in adult rats. Behav. Brain Res. 2003, 141:19-24.
49. Lee W.T., Hong S., Yoon S.H., Kim J.H., Park K.A., Seong G.J., Lee J.E. Neuroprotective effects of agmatine on oxygen-glucose deprived primary-cultured astrocytes and nuclear translocation of nuclear factor-kappa B. Brain Res. 2009, 1281:64-70.
50. Lewis B., Wellmann K.A., Barron S. Agmatine reduces balance deficits in a rat model of third trimester binge-like ethanol exposure. Pharmacol. Biochem. Behav. 2007, 88:114-121.
51. Li G., Regunathan S., Barrow C.J., Eshraghi J., Cooper R., Reis D.J. Agmatine: an endogenous clonidine-displacing substance in the brain. Science 1994, 263:966-969.
52. Li J., Li X., Pei G., Qin B.Y. Correlation between inhibitions of morphine withdrawal and nitric-oxide synthase by agmatine. Zhongguo Yao Li Xue Bao. 1999, 20:375-380.
53. Linnoila M., Eckardt M., Durcan M., Lister R., Martin P. Interactions of serotonin with ethanol: clinical and animal studies. Psychopharmacol. Bull. 1987, 23:452-457.
54. Littleton J.M., Lovinger D., Liljequist S., Ticku R., Matsumoto I., Barron S. Role of polyamines and NMDA receptors in ethanol dependence and withdrawal. Alcohol Clin. Exp. Res. 2001, 25:132S-136S.
55. Liu P., Bergin D.H. Differential effects of i.c.v. microinfusion of agmatine on spatial working and reference memory in the rat. Neuroscience 2009, 159:951-961.
56. Liu P., Rushaidhi M., Collie N.D., Leong M.T., Zhang H. Behavioral effects of intracerebroventricular microinfusion of agmatine in adult rats. Behav. Neurosci. 2008, 122:557-569.
57. Loring R.H. Agmatine acts as an antagonist of neuronal nicotinic receptors. Br. J. Pharmacol. 1990, 99:207-211.
58. Lovinger D.M. Serotonin's role in alcohol's effects on the brain. Alcohol Health Res. World 1997, 2:114-120.
59. Lu G., Su R.B., Li J., Qin B.Y. Modulation by a-difluoromethyl-ornithine and aminoguanidine of pain threshold, morphine analgesia and tolerance. Eur. J. Pharmacol. 2003, 478:139-144.
60. Mao L., Abdel-Rahman A.A. Synergistic behavioral interaction between ethanol and clonidine in rats: role of alpha-2 adrenoceptors. J. Pharmacol. Exp. Ther. 1996, 279:443-449.
61. Mello C.F., Rubin M.A., Sultana R., Barron S., Littleton J.M., Butterfield D.A. Difluoromethylornithine decreases long-lasting protein oxidation induced by neonatal ethanol exposure in the hippocampus of adolescent rats. Alcohol Clin. Exp. Res. 2007, 31:887-894.
62. Mondavio M., Ghiazza G. Use of clonidine in the prevention of alcohol withdrawal syndrome. Minerva Med. 1989, 80:1233-1235.
63. Morgana A.D., Campbellb U.C., Fonsa R.D., Carrolla M.E. Effects of agmatine on the escalation of intravenous cocaine and fentanyl self-administration in rats. Pharmacol. Biochem. Behav. 2002, 72:873-880.
64. Navarro E., Alonso S.J., Martin F.A., Castellano M.A. Toxicological and pharmacological effects of d-arginine. Basic Clin. Pharmacol. Toxicol. 2005, 97:149-154.
65. Nunes-de-Souza R.L., Canto-de-Souza A., da-Costa M., Fornari R.V., Graeff F.G., Pela I.R. Anxiety-induced antinociception in mice: effects of systemic and intra-amygdala administration of 8-OH-DPAT and midazolam. Psychopharmacology 2000, 150:300-310.
66. Onal A., Soykan N. Agmatine produces antinociception in tonic pain in mice. Pharmacol. Biochem. Behav. 2001, 69:93-97.
67. Onal A., Delen Y., Ulker S., Soykan N. Agmatine attenuates neuropathic pain in rats: possible mediation of nitric oxide and noradrenergic activity in the brainstem and cerebellum. Life Sci. 2003, 73:413-428.
68. Opitz K. The effect of clonidine and related substances on voluntary ethanol consumption in rats. Drug Alcohol Depend. 1990, 25:43-48.
69. Otake K., Ruggiero D.A., Regunathan S., Wang H., Milner T.A., Reis D.J. Regional localization of agmatine in the rat brain: an immunocytochemical study. Brain Res. 1998, 787:1-14.
70. Pandey S.C., Zhang D., Mittal N., Nayyar D. Potential role of the gene transcription factor cyclic AMP-responsive element binding protein in ethanol withdrawal-related anxiety. J. Pharmacol. Exp. Ther. 1999, 288:866-878.
71. Parale M.P., Kulkarni S.K. Studies with alpha 2-adrenoceptor agonists and alcohol abstinence syndrome in rats. Psychopharmacology (Berl.) 1986, 88:237-239.
72. Paxinos G., Watson C. The Rat Brain in Stereotaxic Coordinates 1998, Academic Press, London.
73. Pellow S., File S.E. Anxiolytic and anxiogenic drug effects on exploratory activity in an elevated plus-maze: a novel test of anxiety in the rat. Pharmacol. Biochem. Behav. 1986, 24:525-529.
74. Polivy J., Herman C.P. Effects of alcohol on eating behavior: influence of mood and perceived intoxication. J. Abnormal Psychology 1976, 85:601-606.
75. Prendergast M.A., Harris B.R., Blanchard J.A., Mayer S., Gibson D.A., Littleton J.M. In vitro effects of ethanol withdrawal and spermidine on viability of hippocampus from male and female rat. Alcohol Clin. Exp. Res. 2000, 24:1855-1861.
76. Raasch W., Regunathan S., Li G., Reis D.J. Agmatine, the bacterial amine, is widely distributed in mammalian tissues. Life Sci. 1995, 56:2319-2330.
77. Raasch W., Schafer U., Chun J., Dominiak P. Biological significance of agmatine, an endogenous ligand at imidazoline binding sites. Br. J. Pharmacol. 2001, 133:755-780.
78. Regunathan S. Agmatine: biological role and therapeutic potential in morphine analgesia and dependence. AAPS J. 2006, 8:E479-E484.
79. Regunathan S., Reis D.J. Imidazoline receptors and their endogenous ligands. Ann. Rev. Pharmacol. Toxicol. 1996, 36:511-544.
80. Reis D.J., Regunathan S. Agmatine: an endogenous ligand at imidazoline receptors may be a novel neurotransmitter in brain. J. Auton. Nerv. Sys. 1998, 72:80-85.
81. Reis D.J., Regunathan S. Is agmatine a novel neurotransmitter in brain?. Trends Pharmacol. Sci. 2000, 21:187-193.
82. Rezazadeh S.M., Prather P.L., Lal H. Sensitization to 5-HT1C receptor agonist in rats observed following withdrawal from chronic ethanol. Alcohol 1993, 10:281-283.
83. Roberts J.C., Grocholski B.M., Kitto K.F., Fairbanks C.A. Pharmacodynamic and pharmacokinetic studies of agmatine after spinal administration in the mouse. J. Pharmacol. Exp. Ther. 2005, 314:1226-1233.
84. Roelofs S.M. Hyperventilation, anxiety, craving for alcohol: a subacute alcohol withdrawal syndrome. Alcohol 1985, 2:501-505.
85. Rommelspacher H., Schmidt L.G., May T. Plasma norharman (beta-carboline) levels are elevated in chronic alcoholics. Alcohol Clin. Exp. Res. 1991, 15:553-559.
86. Rommelspacher H., Dufeu P., Schmidt L.G. Harman and norharman in alcoholism: correlations with psychopathology and long-term changes. Alcohol Clin. Exp. Res. 1996, 20:3-8.
87. Rosenfeld H.J., Roberts J. Arginine decarboxylase from a Pseudomonas species. J. Bacteriol. 1976, 125:601-607.
88. Satriano J., Schwartz D., Ishizuka S., Lortie M.J., Thomson S.C., Gabbai F., Kelly C.J., Blantz R.C. Suppression of inducible nitric oxide generation by agmatine aldehyde: beneficial effects in sepsis. Cell. Physiol. 2001, 188:313-320.
89. Selamnia M., Mayeur C., Robert V., Blachicr F. Alpha-difluoromethylornithine (DFMO) as a potent arginase activity inhibitor in human colon carcinoma cells. Biochem. Pharmacol. 1998, 55:1241-1245.
90. Sessa A., Perin A. Ethanol and polyamine metabolism: physiologic and pathologic implications: a review. Alcohol Clin. Exp. Res. 1997, 21:318-325.
91. Sessa A., Desiderio M.A., Perin A. Ethanol and polyamine metabolism in adult and fetal tissues: possible implication in fetus damage. Adv. Alcohol Subst. Abuse 1987, 6:73-85.
92. Sharma A.N., Chopde C.T., Hirani K., Kokare D.M., Ugale R.R. Chronic progesterone treatment augments while dehydroepiandrosterone sulphate prevents tolerance to ethanol anxiolysis and withdrawal anxiety in rats. Eur. J. Pharmacol. 2007, 567:211-222.
93. Slotkin T.A., Bartolome J. Role of ornithine decarboxylase and the polyamines in nervous system development: a review. Brain Res. Bull. 1986, 17:307-320.
94. Slotkin T.A., Seidler F.J., Trepanier P.A., Whitmore W.L., Lerea L., Barnes G.A., Weigel S.J., Bartolome J. Ornithine decarboxylase and polyamines in tissues of the neonatal rat: effects of alpha-difluoromethylornithine, a specific, irreversible inhibitor of ornithine decarboxylase. J. Pharmacol. Exp. Ther. 1982, 222:741-745.
95. Spies C.D., Rommelspacher H., Winkler T., Müller C., Brummer G., Funk T., Berger G., Fell M., Blum S., Specht M., Hannemann L., Schaffartzik W. Beta-carbolines in chronic alcoholics following trauma. Addict. Biol. 1996, 1:93-103.
96. Su R.B., Li J., Qin B.Y. Effect of l-arginine and anti-l-arginine decarboxylase antibody on morphine analgesia and tolerance. Chin. J. Drug Depend. 2003, 12:97-101.
97. Su R.B., Wang W.P., Lu X.Q., Wu N., Liu Z.M., Li J. Agmatine blocks acquisition and re-acquisition of intravenous morphine self-administration in rats. Pharmacol. Biochem. Behav. 2009, 92:676-682.
98. Taksande B.G., Kotagale N.R., Tripathi S.J., Ugale R.R., Chopde C.T. Antidepressant like effect of selective serotonin reuptake inhibitors involve modulation of imidazoline receptors by agmatine. Neuropharmacology 2009, 57:415-424.
99. Utkan T., Ulak G., Yildiran H.G., Yardimoglu M., Gacar M.N. Investigation on the mechanism involved in the effects of agmatine on ethanol-induced gastric mucosal injury in rats. Life Sciences 2000, 66:1705-1711.
100. Uzbay I.T., Erden B.F. Attenuation of ethanol withdrawal signs by high doses of l-arginine in rats. Alcohol 2003, 38:213-218.
101. Uzbay I.T., Kayaalp S.O. A modified liquid diet of chronic ethanol administration: validation by ethanol withdrawal syndrome in rats. Pharmacol. Res. 1995, 31:37-42.
102. Uzbay I.T., Akarsu E.S., Kayaalp S.O. Effects of bromocriptine and haloperidol on ethanol withdrawal syndrome in rats. Pharmacol. Biochem. Behav. 1994, 49:969-974.
103. Uzbay I.T., Erden B.F., Tapanyigit E.E., Kayaalp S.O. Nitric oxide synthase inhibition attenuates signs of ethanol withdrawal in rats. Life Sci. 1997, 61:2197-2209.
104. Uzbay I.T., Yeşilyurt O., Celik T., Ergün H., Işimer A. Effects of agmatine on ethanol withdrawal syndrome in rats. Behav. Brain Res. 2000, 107:153-159.
105. Valenzuela C.F. Alcohol and neurotransmitter interactions. Alcohol Health Res. World 1997, 21:141-148.
106. Vandergriff J., Kallman M.J., Rasmussen K. Moxonidine, a selective imidazoline-1 receptor agonist, suppresses the effects of ethanol withdrawal on the acoustic startle response in rats. Biol. Psychiatry 2000, 47:874-879.
107. Yang X.C., Reis D.J. Agmatine selectively blocks the N-methyl-d-aspartate subclass of glutamate receptor channels in rat hippocampal neurons. J. Pharmacol. Exp. Ther. 1999, 288:544-549.
108. Zaniewska M., McCreary A.C., Sezer G., Przegaliński E., Filip M. Effects of agmatine on nicotine-evoked behavioral responses in rats. Pharmacol. Rep. 2008, 60:645-654.
109. Zapata A., Gonzales R.A., Shippenberg T.S. Repeated ethanol intoxication induces behavioral sensitization in the absence of a sensitized accumbens dopamine response in C57BL/6J and DBA/2J Mice. Neuropsychopharmacol 2006, 31:396-405.
110. Zeidan M.P., Zomkowski A.D.E., Rosa A.O., Rodrigues A.L.S., Gabilan N.H. Evidence for imidazoline receptors involvement in the agmatine antidepressant-like effect in the forced swimming test. Eur. J. Pharmacol. 2007, 565:125-131.
111. Zomkowski A.D., Hammes L., Lin J., Calixto J.B., Santos A.R., Rodrigues A.L. Agmatine produces antidepressant-like effects in two models of depression in mice. Neuroreport 2002, 13:387-391.